News & Updates
Showing Cardiology articles
Showing
Triple therapy controls hypertension, dyslipidaemia
Triple therapy with angiotensin receptor blockers (ARBs)/amlodipine + rosuvastatin significantly reduces blood pressure (BP) and cholesterol levels in patients with hypertension and dyslipidaemia compared with dual therapies involving ARBs/amlodipine or ARBs + rosuvastatin, according to a recent study.
Triple therapy controls hypertension, dyslipidaemia
30 Apr 2026
Radiofrequency vs pulsed field ablation: Which approach results in fewer stroke/TIA events?
A single-centre study has found a significantly higher incidence of stroke and transient ischaemic attacks (TIA) within 30 days among patients who underwent pulsed field ablation (PFA) relative to those who received radiofrequency ablation (RFA).
Radiofrequency vs pulsed field ablation: Which approach results in fewer stroke/TIA events?
25 Apr 2026
Lowering BP threshold to 130/80 mm Hg enhances hypertension diagnosis
A significant number of masked, sustained, and nighttime hypertension may not be detected when using the conventional home blood pressure (BP) threshold of 135/85 mm Hg, suggests a study.
Lowering BP threshold to 130/80 mm Hg enhances hypertension diagnosis
24 Apr 2026
Statin-ezetimibe holds slight advantage over PCSK9is in ACS
In a systematic review and network meta-analysis (NMA), a statin-ezetimibe combination yields a more favourable LDL-C reduction and a positive trend in atherosclerotic plaque regression compared with PCSK9 inhibitors (PCSK9is) alone in individuals with acute coronary syndrome (ACS).
